Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation.
作者信息
Konsta M, Rallis E, Karameris A, Stratigos A, Sfikakis P P, Iliopoulos A
出版信息
J Eur Acad Dermatol Venereol. 2012 Feb;26(2):257-8. doi: 10.1111/j.1468-3083.2011.04042.x. Epub 2011 Mar 24.
Abstract
摘要
相似文献
1
Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation.
J Eur Acad Dermatol Venereol. 2012 Feb;26(2):257-8. doi: 10.1111/j.1468-3083.2011.04042.x. Epub 2011 Mar 24.
2
T-cell agents in the treatment of rheumatoid arthritis.
Bull NYU Hosp Jt Dis. 2010;68(3):162-5.
3
Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
Curr Med Res Opin. 2008 Aug;24(8):2283-94. doi: 10.1185/03007990802223129. Epub 2008 Jun 27.
4
T-cell agents in the treatment of rheumatoid arthritis - 2011 update.
Bull NYU Hosp Jt Dis. 2011;69(3):230-2.
5
Letter: A case of generalized guttate psoriasis induced by etanercept with relapse after abatacept.
Dermatol Online J. 2011 Jun 15;17(6):11.
6
Psoriasiform drug eruption due to abatacept.
Acta Derm Venereol. 2011 May;91(3):362-3. doi: 10.2340/00015555-1042.
7
T-cell agents in the treatment of rheumatoid arthritis - 2012 update.
Bull NYU Hosp Jt Dis. 2012;70(3):191-4.
8
[CTLA4-Ig (abatacept)].
Nihon Rinsho. 2007 Jul;65(7):1231-7.
9
Selective costimulation modulation with abatacept: a look at quality-of-life outcomes in patients with rheumatoid arthritis.
Semin Arthritis Rheum. 2009 Jun;38(6):434-43. doi: 10.1016/j.semarthrit.2008.03.009. Epub 2008 Jun 9.
10
Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists.
J Dermatolog Treat. 2006;17(4):229-34. doi: 10.1080/09546630600788885.
引用本文的文献
1
Psoriasiform Drug Eruption Caused by Abatacept: Immunohistochemical Investigation of STAT Signaling.
Case Rep Dermatol. 2015 Jul 24;7(2):166-70. doi: 10.1159/000437415. eCollection 2015 May-Aug.
2
Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.
Drug Saf. 2015 May;38(5):455-79. doi: 10.1007/s40264-015-0285-9.
3
Abatacept in psoriatic arthritis: Case report and short review.
J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S29-32. doi: 10.4103/0976-500X.120943.
Zotero 插件